- 2025.04.02
扶桑薬品工業（株）と共同開発したホストーベクター系が、同社において事業化されました。The host-vector system developed jointly with Fuso Pharmaceutical Industries, Ltd. has been commercialized by the company.
本受託事業は、鈴木教授が扶桑薬品工業（株）と共同開発した哺乳動物細胞を宿主とする組換え蛋白質大量発現ベクターを活用して実施されます。
特許 Canada Patent 2748011 EU patent 2385115 Korea Patent 10-1655492 Hong Kong Patent HK1161898 US Patent 9,096,878 日本国特許第5704753号 Australia Patent 2009331326 China Patent 102325881
詳しくは下記をご覧ください。
This commissioned project will be carried out using a recombinant protein mass expression vector that utilizes mammalian cells as a host, which was jointly developed by Professor Suzuki, the Deputy Director of this center, and Fuso Pharmaceutical Industries, Ltd.
References: Canada Patent 2748011 EU patent 2385115 Korea Patent 10-1655492 Hong Kong Patent HK1161898 US Patent 9,096,878 Japan Patent 5704753 Australia Patent 2009331326 China Patent 102325881
See in detail by the link below.